Hannah M. Cheeseman

Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial

Sonya Abraham, Helene Bæk Juel, Peter Fibiger Bang et al. · The Lancet Infectious Diseases · 2019 · 205 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers

Sandhya Vasan, Arlene Hurley, Sarah J. Schlesinger et al. · PLoS ONE · 2011 · 186 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

Katrina M. Pollock, Hannah M. Cheeseman, Alexander J. Szubert et al. · EClinicalMedicine · 2022 · 162 citations · Full text

Pharmacy, Biotechnology, Immunology +16

Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey

Barnaby Flower, Jonathan C. Brown, Bryony Simmons et al. · Thorax · 2020 · 157 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Airway T cells protect against RSV infection in the absence of antibody

Ekaterina Kinnear, Laura Lambert, Jacqueline U. McDonald et al. · Mucosal Immunology · 2017 · 114 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14